Brief: PharmAbcine Enters Into Research Collaboration Agreement With LegoChem Biosciences
11/01/2021 13:50
Jan 11 (Reuters) - PharmAbcine Inc 208340.KQ :
* PHARMABCINE INC - ENTERED INTO A RESEARCH COLLABORATION
AGREEMENT WITH LEGOCHEM BIOSCIENCES INC.
* PHARMABCINE INC - UNDER AGREEMENT, CO WILL PROVIDE PMC-403
TO
LCB SO LCB CAN CONDUCT A COMBINATION RESEARCH USING PMC-403 AND
LCB'S PROPRIETARY ADC
Source text for Eikon: ID:nPnbsJd5Ma
Further company coverage: 208340.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LigaChem Biosciences
See all newsBrief: Ligachem Biosciences - Receives Milestone Payment For First Patient Dosing Of 'Lcb97' Licensed To Ono Pharmaceutical
Brief: Ligachem Biosciences To Issue 170 Billion Won Worth Of Convertible Bonds
Brief: Ligachem Biosciences - Issues 2.21 Million New Preferred Shares
Brief: Ligachem Biosciences To Divest 5 Billion Won Worth Of Own Shares
Brief: Ligachem Biosciences To Divest 17 Billion Won Worth Of Own Shares